Track record · closed signal

Amentum Holdings, Inc. (AMTM) — closed signal from March 2, 2026

Partial Published before the outcome was known, scored automatically when the window closed on May 31, 2026.

Predicted vs. what happened

AMTM price · publication thesis → realized outcomesplit-adjusted
$30.75 Published $35.98 Target $23.84 Window close $31.37 Peak
$29.00 – $31.50Entry zone — fair-value band
$30.75Published — price the day we called it
$35.98Target — the price the thesis aimed for
$31.37Peak — highest point inside the window, not a realized return
$23.84Window close — end-of-window price, context only

What happened

Partial

Reached 12% of the predicted growth at its peak, without hitting the target.

Peak price
$31.37
peak on March 4, 2026 — not a realized return
Peak gain
+2%
peak, from the publication price
Window close
$23.84
end-of-window price, context only
Days to target
Window
March 2, 2026 – May 31, 2026

The thesis — published March 2, 2026

Predicted growth
+17%
over the measurement window
Target price
$35.98
the price the thesis aimed for
Entry zone
$29.00 – $31.50
the fair-value band we waited for
Price at publication
$30.75
published March 2, 2026
Confidence
69%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

The company just reported a solid quarter, won new nuclear contracts, and set revenue targets for the year. Models show the stock might be a bit cheap if investor mood improves. That makes this a short-term rebound idea, but it can stay choppy if government funding news or market risk sentiment reverses. Trade in stages and cut losses if support fails.

Primary drivers

  • Strong recent quarter and yearly guidance support the recovery story
  • New nuclear contracts strengthen expected future work
  • Valuation work suggests modest upside if sentiment returns to normal
  • Stock is volatile; use staged buying and strict stop rules

How it played out

AMTM: the rebound thesis missed

Lyra published AMTM on 2026-03-02 at 30.75 as a short-term rebound idea with 17% expected growth. The thesis pointed to a solid recent quarter, yearly guidance, new nuclear contracts, and valuation work that suggested modest upside if sentiment returned to normal. It also said the stock could stay choppy if government funding news or market risk sentiment reversed.

Inside the window, AMTM peaked at 31.37 on 2026-03-04, a 2% gain. That stayed below the 35.98 target, so the target was never reached. By 2026-05-31, it ended at 23.84. The thesis missed.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.